STOCK TITAN

Colony Bankcorp Financials

CBAN
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Colony Bankcorp (CBAN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CBAN FY2025

FY2025 balance-sheet expansion lifted accounting earnings, but cash generation flipped negative as the bank carried a much larger asset base.

After several years of positive operating cash flow, net income still reached $28.3M even as operating cash flow slipped to -$5.5M, showing that reported earnings stopped converting into cash. Because assets expanded sharply and equity rose to $375.9M, the bank funded that growth with a thicker capital base, which pushed ROE down to 7.5%.

The clearest structural shift is capital deepening: equity increased by nearly $97M, far faster than long-term debt, which made the balance sheet less leveraged without relying on a matching jump in borrowings. With ROA still near 0.8% and debt-to-equity down to 0.7x, the larger equity base diluted shareholder returns.

A second pattern is fixed-cost absorption: overhead was still only about $52M even as revenue reached $150.0M. That steadier expense base let net income keep advancing, so the weaker ROE reflects more capital on the balance sheet, not a collapse in core profitability.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 22 / 100
Financial Profile 22/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Colony Bankcorp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
0

Colony Bankcorp's revenue declined 74.1% year-over-year, from $137.2M to $35.5M. This contraction results in a growth score of 0/100.

Leverage
88

Colony Bankcorp carries a low D/E ratio of 0.69, meaning only $0.69 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 88/100, indicating a strong balance sheet with room for future borrowing.

Cash Flow
20

While Colony Bankcorp generated -$5.5M in operating cash flow, capex of $1.4M consumed most of it, leaving -$6.9M in free cash flow. This results in a low score of 20/100, reflecting heavy capital investment rather than weak cash generation.

Returns
23

Colony Bankcorp generates a 1.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 23/100. This is down from 8.6% the prior year.

Piotroski F-Score Weak
2/9

Colony Bankcorp passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality
-0.84x

For every $1 of reported earnings, Colony Bankcorp generates $-0.84 in operating cash flow (-$5.5M OCF vs $6.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$35.5M
YoY-74.1%
5Y CAGR-10.9%
10Y CAGR-2.2%

Colony Bankcorp generated $35.5M in revenue in fiscal year 2026. This represents a decrease of 74.1% from the prior year.

EBITDA
N/A
Net Income
$6.6M
YoY-72.3%
5Y CAGR-11.0%
10Y CAGR-2.3%

Colony Bankcorp reported $6.6M in net income in fiscal year 2026. This represents a decrease of 72.3% from the prior year.

EPS (Diluted)
$0.38
YoY-72.1%
5Y CAGR-21.1%
10Y CAGR-6.1%

Colony Bankcorp earned $0.38 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 72.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$6.9M
YoY-130.9%

Colony Bankcorp generated -$6.9M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 130.9% from the prior year.

Cash & Debt
$257.6M
YoY+11.5%
5Y CAGR+7.0%
10Y CAGR+27.7%

Colony Bankcorp held $257.6M in cash against $258.1M in long-term debt as of fiscal year 2026.

Dividends Per Share
$0.12
YoY-74.4%
5Y CAGR-22.1%

Colony Bankcorp paid $0.12 per share in dividends in fiscal year 2026. This represents a decrease of 74.4% from the prior year.

Shares Outstanding
21M
YoY+21.3%
5Y CAGR+17.5%
10Y CAGR+9.7%

Colony Bankcorp had 21M shares outstanding in fiscal year 2026. This represents an increase of 21.3% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
18.6%
YoY+1.2pp
5Y CAGR-0.1pp
10Y CAGR-0.3pp

Colony Bankcorp's net profit margin was 18.6% in fiscal year 2026, showing the share of revenue converted to profit. This is up 1.2 percentage points from the prior year.

Return on Equity
1.8%
YoY-6.8pp
5Y CAGR-6.4pp
10Y CAGR-7.0pp

Colony Bankcorp's ROE was 1.8% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 6.8 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$2.4M
YoY+81.5%

Colony Bankcorp spent $2.4M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 81.5% from the prior year.

Capital Expenditures
$1.4M
YoY+25.4%
5Y CAGR-20.4%
10Y CAGR-8.2%

Colony Bankcorp invested $1.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 25.4% from the prior year.

CBAN Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $44.9M+10.3% $40.7M+10.3% $36.9M+0.2% $36.8M+3.7% $35.5M-1.3% $36.0M+4.0% $34.6M+3.8% $33.3M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $15.9M+12.8% $14.1M+4.3% $13.5M+5.2% $12.9M+8.1% $11.9M-7.5% $12.9M+2.2% $12.6M+2.6% $12.3M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $15.7M+5.7% $14.8M+4.5% $14.2M-1.8% $14.4M-0.8% $14.6M-6.1% $15.5M-3.4% $16.1M+7.6% $14.9M
Income Tax $2.3M+32.6% $1.7M+17.2% $1.5M-28.9% $2.1M+23.4% $1.7M+16.5% $1.4M+1.3% $1.4M-3.0% $1.5M
Net Income $8.2M+4.6% $7.8M+34.8% $5.8M-27.1% $8.0M+20.6% $6.6M-11.0% $7.4M+32.0% $5.6M+2.8% $5.5M
EPS (Diluted) $0.39 N/A $0.33-28.3% $0.46+21.1% $0.38 N/A $0.32+3.2% $0.31

CBAN Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $3.7B-0.4% $3.7B+18.5% $3.2B+1.2% $3.1B-1.8% $3.2B+2.0% $3.1B+1.5% $3.1B+1.9% $3.0B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $295.8M+14.8% $257.6M+28.8% $200.0M+78.3% $112.1M-49.3% $221.2M-4.3% $231.0M+59.5% $144.9M+76.6% $82.0M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $63.0M-1.3% $63.9M+25.6% $50.9M0.0% $50.9M+4.0% $48.9M0.0% $48.9M0.0% $48.9M0.0% $48.9M
Total Liabilities $3.3B-0.6% $3.4B+17.9% $2.9B+1.0% $2.8B-2.2% $2.9B+1.9% $2.8B+1.5% $2.8B+1.7% $2.7B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $38.9M-84.9% $258.1M N/A N/A N/A $248.0M N/A N/A
Total Equity $380.4M+1.2% $375.9M+24.3% $302.3M+2.9% $293.9M+2.4% $286.9M+3.0% $278.7M+1.0% $276.1M+4.3% $264.7M
Retained Earnings $166.2M+3.5% $160.6M+3.8% $154.7M+2.5% $150.9M+4.1% $145.0M+3.3% $140.4M+4.0% $134.9M+2.8% $131.3M

CBAN Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $54.3M+200.9% -$53.7M-472.9% $14.4M-9.0% $15.8M-11.7% $17.9M+653.3% -$3.2M-115.8% $20.5M+1729.9% $1.1M
Capital Expenditures $421K-26.4% $572K+63.0% $351K+312.9% $85K-75.4% $346K-38.4% $562K+95.8% $287K+120.8% $130K
Free Cash Flow $53.8M+199.1% -$54.3M-486.3% $14.1M-10.8% $15.8M-10.5% $17.6M+562.5% -$3.8M-118.8% $20.2M+1941.2% $990K
Investing Cash Flow $7.4M-91.9% $91.1M+91.7% $47.5M+185.5% -$55.6M+30.1% -$79.6M-262.7% $49.0M+14217.0% $342K-64.0% $951K
Financing Cash Flow -$23.4M-215.6% $20.3M-21.6% $25.9M+137.3% -$69.3M-233.5% $51.9M+28.2% $40.5M-3.7% $42.0M+385.1% -$14.7M
Dividends Paid $2.6M+27.1% $2.0M-0.1% $2.0M+0.1% $2.0M-0.4% $2.0M+2.1% $2.0M-0.1% $2.0M-0.1% $2.0M
Share Buybacks $1.8M+126.7% $779K $0-100.0% $959K+52.2% $630K+16.7% $540K+2.7% $526K+120.1% $239K

CBAN Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 18.3%-1.0pp 19.3%+3.5pp 15.8%-5.9pp 21.7%+3.0pp 18.6%-2.0pp 20.6%+4.4pp 16.3%-0.2pp 16.4%
Return on Equity 2.2%+0.1pp 2.1%+0.2pp 1.9%-0.8pp 2.7%+0.4pp 2.3%-0.4pp 2.7%+0.6pp 2.0%-0.0pp 2.1%
Return on Assets 0.2%+0.0pp 0.2%+0.0pp 0.2%-0.1pp 0.3%+0.1pp 0.2%-0.0pp 0.2%+0.1pp 0.2%0.0pp 0.2%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 8.78+8.1 0.69-8.7 9.43-0.2 9.60-0.5 10.05+9.2 0.89-9.2 10.10-0.3 10.36
FCF Margin 119.9%+253.4pp -133.4%-171.6pp 38.1%-4.7pp 42.8%-6.8pp 49.5%+60.1pp -10.6%-69.0pp 58.4%+55.4pp 3.0%

Similar Companies

Frequently Asked Questions

Colony Bankcorp (CBAN) reported $35.5M in total revenue for fiscal year 2026. This represents a -74.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Colony Bankcorp (CBAN) revenue declined by 74.1% year-over-year, from $137.2M to $35.5M in fiscal year 2026.

Yes, Colony Bankcorp (CBAN) reported a net income of $6.6M in fiscal year 2026, with a net profit margin of 18.6%.

Colony Bankcorp (CBAN) reported diluted earnings per share of $0.38 for fiscal year 2026. This represents a -72.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2026, Colony Bankcorp (CBAN) had $257.6M in cash and equivalents against $258.1M in long-term debt.

Colony Bankcorp (CBAN) had a net profit margin of 18.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Yes, Colony Bankcorp (CBAN) paid $0.12 per share in dividends during fiscal year 2026.

Colony Bankcorp (CBAN) has a return on equity of 1.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Colony Bankcorp (CBAN) generated -$6.9M in free cash flow during fiscal year 2026. This represents a -130.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Colony Bankcorp (CBAN) generated -$5.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Colony Bankcorp (CBAN) had $3.7B in total assets as of fiscal year 2026, including both current and long-term assets.

Colony Bankcorp (CBAN) invested $1.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, Colony Bankcorp (CBAN) spent $2.4M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Colony Bankcorp (CBAN) had 21M shares outstanding as of fiscal year 2026.

Colony Bankcorp (CBAN) had a debt-to-equity ratio of 0.69 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Colony Bankcorp (CBAN) had a return on assets of 0.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2026 data, Colony Bankcorp (CBAN) had $257.6M in cash against an annual operating cash burn of $5.5M. This gives an estimated cash runway of approximately 558 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Colony Bankcorp (CBAN) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Colony Bankcorp (CBAN) has an earnings quality ratio of -0.84x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Colony Bankcorp (CBAN) scores 22 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top